Trials / Completed
CompletedNCT00631566
Prospective Study of Methicillin-Resistant Staphylococcus Aureus (MRSA) Among HIV-Infected Persons
Prospective Study on the Incidence, Predictors, and Characteristics of Methicillin-Resistant Staphylococcus Aureus Infections and a Randomized, Double-Blind Study on Decolonization Procedures for Prevention of MRSA Infections Among HIV-Infected Persons
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 550 (actual)
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will prospectively evaluate the prevalence and incidence (over a two year period) of MRSA colonization and infection among HIV-infected military beneficiaries to determine predictors for the development of MRSA colonization and infection. This study will also investigate the utility of decolonization procedures for clearance of MRSA carriage and prevention of MRSA infections. Finally, the molecular characteristics and the antimicrobial sensitivities of isolates in this population will be determined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mupirocin (Bactroban) 2%; hexachlorophene (pHisoHex) 3% | BACTROBAN NASAL is a white to off-white ointment that contains 2.15% w/w mupirocin calcium (equivalent to 2.0% pure mupirocin free acid) in a soft white ointment base. The inactive ingredients are paraffin and a mixture of glycerin esters (SOFTISAN 649). pHisoHex, brand of hexachlorophene detergent cleanser, is an antibacterial sudsing emulsion for topical administration. Some randomized patients will receive mupirocin (Bactroban) nasal ointment plus hexachlorophene (pHisoHex) body washes for seven days. |
| DRUG | Placebo | Some randomized patients will receive a placebo nasal ointment (white petroleum) and a placebo body soap with no antimicrobial activity for seven days. |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2017-05-01
- Completion
- 2017-10-01
- First posted
- 2008-03-07
- Last updated
- 2023-03-03
- Results posted
- 2018-08-16
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00631566. Inclusion in this directory is not an endorsement.